PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.09%
Negative revenue growth while 6617.T stands at 8.04%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
20.02%
Gross profit growth above 1.5x 6617.T's 11.64%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
220.05%
EBIT growth above 1.5x 6617.T's 50.31%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
433.12%
Operating income growth above 1.5x 6617.T's 59.58%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
584.80%
Net income growth above 1.5x 6617.T's 48.56%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
586.19%
EPS growth above 1.5x 6617.T's 48.46%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
586.19%
Diluted EPS growth above 1.5x 6617.T's 48.50%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Share reduction while 6617.T is at 0.06%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 6617.T is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
2.62%
OCF growth under 50% of 6617.T's 8.98%. Michael Burry might suspect questionable revenue recognition or rising costs.
2.62%
FCF growth under 50% of 6617.T's 8.98%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
68.20%
10Y CAGR of 68.20% while 6617.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
10.27%
5Y revenue/share CAGR similar to 6617.T's 10.12%. Walter Schloss might see both companies benefiting from the same mid-term trends.
2.58%
Positive 3Y CAGR while 6617.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.33%
10Y net income/share CAGR of 70.33% while 6617.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
614.27%
5Y net income/share CAGR above 1.5x 6617.T's 160.84%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-27.77%
Negative 3Y CAGR while 6617.T is 0.18%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
355.71%
10Y equity/share CAGR above 1.5x 6617.T's 12.57%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
41.84%
5Y equity/share CAGR above 1.5x 6617.T's 13.21%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
24.87%
3Y equity/share CAGR above 1.5x 6617.T's 12.75%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.00%
Firm’s AR is declining while 6617.T shows 3.70%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
10.48%
Inventory growth well above 6617.T's 6.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.49%
Negative asset growth while 6617.T invests at 2.13%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.76%
BV/share growth above 1.5x 6617.T's 1.00%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-8.16%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
7.59%
We increase R&D while 6617.T cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-1.72%
We cut SG&A while 6617.T invests at 2.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.